Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2019

01-04-2019 | Human Immunodeficiency Virus

Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults’ Perspectives

Authors: Christina J. Sun, PhD, MS, Kirsten M. Anderson, MPH, MSW, David Bangsberg, MD, MSc, MPH, Kim Toevs, MPH, Dayna Morrison, MPH, Caitlin Wells, BA, BS, Pete Clark, BA, Christina Nicolaidis, MD, MPH

Published in: Journal of General Internal Medicine | Issue 4/2019

Login to get access

Abstract

Background

Sexual and gender minority (SGM) populations remain at disproportionate risk of HIV infection. Despite the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV, PrEP uptake has been slow.

Objective

To identify barriers and facilitators of PrEP access by examining SGM patients’ experiences with accessing health care systems and engaging with providers about PrEP in a variety of practice settings.

Design

Semi-structured, individual, qualitative interviews.

Participants

Twenty-seven sexual and gender minority adults residing in Oregon.

Approach

Interviews were audio-recorded, transcribed, and analyzed using thematic analysis.

Key Results

We identified three main themes. Participants described the centrality of patient-provider relationships to positive experiences around PrEP, the necessity of personally advocating to access PrEP, and the experience of system-level barriers to PrEP access. Participants also made several suggestions to improve PrEP access including improving provider engagement with SGM patients, encouraging providers to initiate conversations about PrEP, and increasing awareness of medication financial support.

Conclusions

In order to reduce HIV disparities, improving PrEP access will require additional efforts by providers and resources across health care settings to reduce barriers. Interventions to improve provider education about PrEP and provider communication skills for discussing sexual health are needed. Additionally, there should be system-level improvements to increase coordination between patients, providers, pharmacies, and payers to facilitate PrEP access and uptake.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveill Suppl Rep. 2018;23(1). Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveill Suppl Rep. 2018;23(1).
2.
go back to reference Gilead. U.S. Food and Drug Administration approves Gilead’s Truvada® for reducing the risk of acquiring HIV. Available at: https://www.gilead.com/news/press-releases/2012/7/us-food-and-drug-administration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv. Accessed November 13, 2018. Gilead. U.S. Food and Drug Administration approves Gilead’s Truvada® for reducing the risk of acquiring HIV. Available at: https://​www.​gilead.​com/​news/​press-releases/​2012/​7/​us-food-and-drug-administration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv.​ Accessed November 13, 2018.
3.
go back to reference Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973–1983.CrossRefPubMedPubMedCentral Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973–1983.CrossRefPubMedPubMedCentral
4.
go back to reference Grant R, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599.CrossRefPubMedPubMedCentral Grant R, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599.CrossRefPubMedPubMedCentral
5.
go back to reference Grohskopf LA, Chillag KL, Gvetadze R, et al. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013;64(1):79–86.CrossRefPubMed Grohskopf LA, Chillag KL, Gvetadze R, et al. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013;64(1):79–86.CrossRefPubMed
6.
go back to reference McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRefPubMedPubMedCentral McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60.CrossRefPubMedPubMedCentral
7.
go back to reference Spinner CD, Boesecke C, Zink A, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151–158.CrossRefPubMed Spinner CD, Boesecke C, Zink A, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151–158.CrossRefPubMed
9.
go back to reference Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61(10):1601–1603.CrossRefPubMedPubMedCentral Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61(10):1601–1603.CrossRefPubMedPubMedCentral
10.
go back to reference Okwundu CI, Uthman OA, Okoromah CAN. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;(7):CD007189. Okwundu CI, Uthman OA, Okoromah CAN. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;(7):CD007189.
12.
go back to reference Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–1597.CrossRefPubMedPubMedCentral Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–1597.CrossRefPubMedPubMedCentral
13.
go back to reference Parsons JT, Rendina HJ, Lassiter JM, Whit THF, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. J Acquir Immune Defic Syndr. 2017;74(3):285–292.CrossRefPubMedPubMedCentral Parsons JT, Rendina HJ, Lassiter JM, Whit THF, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. J Acquir Immune Defic Syndr. 2017;74(3):285–292.CrossRefPubMedPubMedCentral
14.
go back to reference Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee S-J, Leibowitz AA. Motivators, concerns, and barriers to adoption of pre-exposure prophylaxis for HIV prevention among gay and bisexual men in HIV serodiscordant male relationships. AIDS Care. 2011;23(9):1136–1145.CrossRefPubMedPubMedCentral Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee S-J, Leibowitz AA. Motivators, concerns, and barriers to adoption of pre-exposure prophylaxis for HIV prevention among gay and bisexual men in HIV serodiscordant male relationships. AIDS Care. 2011;23(9):1136–1145.CrossRefPubMedPubMedCentral
15.
go back to reference Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7(1):116.CrossRefPubMedPubMedCentral Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7(1):116.CrossRefPubMedPubMedCentral
16.
go back to reference Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7(11):e50061.CrossRefPubMedPubMedCentral Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7(11):e50061.CrossRefPubMedPubMedCentral
17.
go back to reference Thomann M, Grosso A, Zapata R, Chiasson MA. “WTF is PrEP?”: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Cult Health Sex. 2018;20(7):772–786.CrossRefPubMed Thomann M, Grosso A, Zapata R, Chiasson MA. “WTF is PrEP?”: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Cult Health Sex. 2018;20(7):772–786.CrossRefPubMed
18.
go back to reference Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMed Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMed
19.
go back to reference Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res. 2013;11(7):520–527.CrossRefPubMedPubMedCentral Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res. 2013;11(7):520–527.CrossRefPubMedPubMedCentral
20.
go back to reference Hannaford A, Lipshie-Williams M, Starrels JL, et al. The use of online posts to identify barriers to and facilitators of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men: a comparison to a systematic review of the peer-reviewed literature. AIDS Behav. 2018;22(4):1080–1095.CrossRefPubMedPubMedCentral Hannaford A, Lipshie-Williams M, Starrels JL, et al. The use of online posts to identify barriers to and facilitators of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men: a comparison to a systematic review of the peer-reviewed literature. AIDS Behav. 2018;22(4):1080–1095.CrossRefPubMedPubMedCentral
21.
go back to reference Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–254.CrossRefPubMedPubMedCentral Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248–254.CrossRefPubMedPubMedCentral
22.
go back to reference Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.CrossRefPubMedPubMedCentral Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.CrossRefPubMedPubMedCentral
23.
go back to reference Grace D, Jollimore J, MacPherson P, Strang MJP, Tan DHS. The pre-exposure prophylaxis-stigma paradox: learning from Canada’s first wave of PrEP users. AIDS Patient Care STDS. 2018;32(1):24–30.CrossRefPubMedPubMedCentral Grace D, Jollimore J, MacPherson P, Strang MJP, Tan DHS. The pre-exposure prophylaxis-stigma paradox: learning from Canada’s first wave of PrEP users. AIDS Patient Care STDS. 2018;32(1):24–30.CrossRefPubMedPubMedCentral
24.
go back to reference Gilmore HJ, Liu A, Koester KA, et al. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDS. 2013;27(10):560–566.CrossRefPubMedPubMedCentral Gilmore HJ, Liu A, Koester KA, et al. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDS. 2013;27(10):560–566.CrossRefPubMedPubMedCentral
25.
go back to reference Hosek SG, Rudy B, Landovitz R, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21–29.CrossRefPubMedPubMedCentral Hosek SG, Rudy B, Landovitz R, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21–29.CrossRefPubMedPubMedCentral
26.
go back to reference Carlo Hojilla J, Koester KA, Cohen SE, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461–1469.CrossRefPubMed Carlo Hojilla J, Koester KA, Cohen SE, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461–1469.CrossRefPubMed
27.
go back to reference Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Intern Med. 2016;176(1):75–84.CrossRefPubMedPubMedCentral Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Intern Med. 2016;176(1):75–84.CrossRefPubMedPubMedCentral
28.
go back to reference Koester K, Amico RK, Gilmore H, et al. Risk, safety and sex among male PrEP users: time for a new understanding. Cult Health Sex. 2017;19(12):1301–1313.CrossRefPubMed Koester K, Amico RK, Gilmore H, et al. Risk, safety and sex among male PrEP users: time for a new understanding. Cult Health Sex. 2017;19(12):1301–1313.CrossRefPubMed
29.
go back to reference Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, et al. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care. 2016;28(Suppl 1):48–55.CrossRefPubMedPubMedCentral Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, et al. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care. 2016;28(Suppl 1):48–55.CrossRefPubMedPubMedCentral
30.
go back to reference Amico KR, Mehrotra M, Avelino-Silva VI, et al. Self-reported recent PrEP dosing and drug detection in an open label PrEP study. AIDS Behav. 2016;20(7):1535–1540.CrossRefPubMedPubMedCentral Amico KR, Mehrotra M, Avelino-Silva VI, et al. Self-reported recent PrEP dosing and drug detection in an open label PrEP study. AIDS Behav. 2016;20(7):1535–1540.CrossRefPubMedPubMedCentral
31.
go back to reference Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–3691.CrossRefPubMedPubMedCentral Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–3691.CrossRefPubMedPubMedCentral
32.
go back to reference Calabrese SK, Magnus M, Mayer KH, et al. “Support your client at the space that they’re in”: HIV pre-exposure prophylaxis (PrEP) prescriber’s perspectives on PrEP-related risk compensation. AIDS Patient Care STDS. 2017;31(4):196–204.CrossRefPubMedPubMedCentral Calabrese SK, Magnus M, Mayer KH, et al. “Support your client at the space that they’re in”: HIV pre-exposure prophylaxis (PrEP) prescriber’s perspectives on PrEP-related risk compensation. AIDS Patient Care STDS. 2017;31(4):196–204.CrossRefPubMedPubMedCentral
33.
go back to reference Patel RR, Chan PA, Harrison LC, et al. Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis, Missouri. LGBT Heal. 2018;5(4):250–256.CrossRef Patel RR, Chan PA, Harrison LC, et al. Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis, Missouri. LGBT Heal. 2018;5(4):250–256.CrossRef
34.
go back to reference Mullins TLK, Lally M, Zimet G, Kahn JA. Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents. AIDS Patient Care STDS. 2015;29(4):193–203.CrossRefPubMedPubMedCentral Mullins TLK, Lally M, Zimet G, Kahn JA. Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents. AIDS Patient Care STDS. 2015;29(4):193–203.CrossRefPubMedPubMedCentral
35.
go back to reference White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395–405.CrossRefPubMedPubMedCentral White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395–405.CrossRefPubMedPubMedCentral
36.
go back to reference Marcus JL, Volk JE, Pinder J, et al. Successful implementation of HIV pre-exposure prophylaxis: lessons learned from three clinical settings. Curr HIV/AIDS Rep. 2016;13(2):116–124.CrossRefPubMed Marcus JL, Volk JE, Pinder J, et al. Successful implementation of HIV pre-exposure prophylaxis: lessons learned from three clinical settings. Curr HIV/AIDS Rep. 2016;13(2):116–124.CrossRefPubMed
37.
go back to reference Parker S, Chan PA, Oldenburg CE, et al. Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care STDS. 2015;29(12):639–642.CrossRefPubMedPubMedCentral Parker S, Chan PA, Oldenburg CE, et al. Patient experiences of men who have sex with men using pre-exposure prophylaxis to prevent HIV infection. AIDS Patient Care STDS. 2015;29(12):639–642.CrossRefPubMedPubMedCentral
38.
go back to reference Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS One. 2017;12(2):e0172354.CrossRefPubMedPubMedCentral Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS One. 2017;12(2):e0172354.CrossRefPubMedPubMedCentral
39.
go back to reference Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of pre-exposure prophylaxis for HIV prevention among men who have sex with men at a New England sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717–723.CrossRefPubMedPubMedCentral Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of pre-exposure prophylaxis for HIV prevention among men who have sex with men at a New England sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717–723.CrossRefPubMedPubMedCentral
41.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
42.
go back to reference Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1–13.CrossRef Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1–13.CrossRef
43.
go back to reference Hoffman S, Guidry JA, Collier KL, et al. A clinical home for preexposure prophylaxis: diverse health care providers’ perspectives on the “purview paradox.”. J Int Assoc Provid AIDS Care. 2016;15(1):59–65.CrossRefPubMed Hoffman S, Guidry JA, Collier KL, et al. A clinical home for preexposure prophylaxis: diverse health care providers’ perspectives on the “purview paradox.”. J Int Assoc Provid AIDS Care. 2016;15(1):59–65.CrossRefPubMed
44.
go back to reference Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–1721.CrossRefPubMedPubMedCentral Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–1721.CrossRefPubMedPubMedCentral
45.
go back to reference Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7(7):e40603.CrossRefPubMedPubMedCentral Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7(7):e40603.CrossRefPubMedPubMedCentral
46.
go back to reference Krakower DS, Maloney KM, Grasso C, Melbourne K, Mayer KH. Primary care clinicians’ experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016;19(1):21165.CrossRefPubMedPubMedCentral Krakower DS, Maloney KM, Grasso C, Melbourne K, Mayer KH. Primary care clinicians’ experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016;19(1):21165.CrossRefPubMedPubMedCentral
47.
go back to reference Krakower DS, Ware NC, Maloney KM, Wilson IB, Wong JB, Mayer KH. Differing experiences with pre-exposure prophylaxis in Boston among lesbian, gay, bisexual, and transgender specialists and generalists in primary care: implications for scale-up. AIDS Patient Care STDS. 2017;31(7):297–304.CrossRefPubMedPubMedCentral Krakower DS, Ware NC, Maloney KM, Wilson IB, Wong JB, Mayer KH. Differing experiences with pre-exposure prophylaxis in Boston among lesbian, gay, bisexual, and transgender specialists and generalists in primary care: implications for scale-up. AIDS Patient Care STDS. 2017;31(7):297–304.CrossRefPubMedPubMedCentral
48.
go back to reference Underhill K, Morrow KM, Colleran CM, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the U.S. PLoS One. 2014;9(11):e112425.CrossRefPubMedPubMedCentral Underhill K, Morrow KM, Colleran CM, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the U.S. PLoS One. 2014;9(11):e112425.CrossRefPubMedPubMedCentral
49.
go back to reference Bien CH, Patel VV., Blackstock OJ, Felsen UR. Reaching key populations: PrEP uptake in an urban health care system in the Bronx, New York. AIDS Behav. 2017;21(5):1309–1314.CrossRefPubMed Bien CH, Patel VV., Blackstock OJ, Felsen UR. Reaching key populations: PrEP uptake in an urban health care system in the Bronx, New York. AIDS Behav. 2017;21(5):1309–1314.CrossRefPubMed
50.
go back to reference Braksmajer A, Fedor TM, Chen SR, et al. Willingness to take prep for HIV prevention: the combined effects of race/ethnicity and provider trust. AIDS Educ Prev. 2018;30(1):1–12.CrossRefPubMed Braksmajer A, Fedor TM, Chen SR, et al. Willingness to take prep for HIV prevention: the combined effects of race/ethnicity and provider trust. AIDS Educ Prev. 2018;30(1):1–12.CrossRefPubMed
51.
go back to reference Blackstock OJ, Moore BA, Berkenblit G V., et al. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2017;32(1):62–70.CrossRefPubMed Blackstock OJ, Moore BA, Berkenblit G V., et al. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2017;32(1):62–70.CrossRefPubMed
52.
go back to reference Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among U.S. primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–1267.CrossRefPubMedPubMedCentral Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among U.S. primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–1267.CrossRefPubMedPubMedCentral
53.
go back to reference Blumenthal J, Jain S, Krakower D, et al. Knowledge is power!: increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescript PrEP. AIDS Behav. 2015;19(5):802–810.CrossRefPubMedPubMedCentral Blumenthal J, Jain S, Krakower D, et al. Knowledge is power!: increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescript PrEP. AIDS Behav. 2015;19(5):802–810.CrossRefPubMedPubMedCentral
54.
55.
go back to reference Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, D.C.: The National Academies Press; 2011. Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, D.C.: The National Academies Press; 2011.
56.
go back to reference Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three U.S. cities. J Int AIDS Soc. 2016;19(1):20903.CrossRefPubMedPubMedCentral Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three U.S. cities. J Int AIDS Soc. 2016;19(1):20903.CrossRefPubMedPubMedCentral
57.
go back to reference Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives preexposure prophylaxis (PrEP)?: a brief online survey of medical providers’ PrEP practices. Heal Educ Behav. 2018;45(5):723–729.CrossRef Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives preexposure prophylaxis (PrEP)?: a brief online survey of medical providers’ PrEP practices. Heal Educ Behav. 2018;45(5):723–729.CrossRef
Metadata
Title
Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults’ Perspectives
Authors
Christina J. Sun, PhD, MS
Kirsten M. Anderson, MPH, MSW
David Bangsberg, MD, MSc, MPH
Kim Toevs, MPH
Dayna Morrison, MPH
Caitlin Wells, BA, BS
Pete Clark, BA
Christina Nicolaidis, MD, MPH
Publication date
01-04-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 4/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-04850-w

Other articles of this Issue 4/2019

Journal of General Internal Medicine 4/2019 Go to the issue